conv.

← The whole story
Health
FDA examines testosterone therapy for menopausal women amid rising off-label use

FDA public workshop on testosterone therapy convenes

2 Sep 18 1:17 PM · 5d ago · 2 articles · 1 post · 2 sources · development 2 of 2

The FDA held the public workshop on Thursday to examine testosterone therapy use in menopausal women. Specialists at the workshop cautioned that key questions about the therapy's long-term safety remain unanswered.

FDA public workshop on testosterone therapy convenes
abcnews.com

“We do not have any evidence in women that it will improve muscle mass or bone density or mood or well-being or really any other metric.”

Dr. Stephanie Faubion

Dr. Stephanie Faubion Director, Mayo Clinic Center for Women's HealthDr. Diana Tordoff Instructor in obstetrics and gynecology, StanfordDr. Karen Adams Director, Stanford Medicine's Program in Menopause and Healthy AgingFDA US health regulator

The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump

Peak 2 pieces in two hours at Sep 17, 5 AM; 7 pieces over 7 days (6 articles · 1 post) Sep 17, 5 AM — 2 pieces · 2 articles — Google News 1, Newswires 1Sep 17, 7 AM — 1 piece · 1 article — Newswires 1Sep 17, 9 AM — quietSep 17, 11 AM — quietSep 17, 1 PM — quietSep 17, 3 PM — quietSep 17, 5 PM — quietSep 17, 7 PM — quietSep 17, 9 PM — quietSep 17, 11 PM — quietSep 18, 1 AM — quietSep 18, 3 AM — quietSep 18, 5 AM — quietSep 18, 7 AM — quietSep 18, 9 AM — quietSep 18, 11 AM — 1 piece · 1 article — Newswires 1Sep 18, 1 PM — quietSep 18, 3 PM — quietSep 18, 5 PM — 2 pieces · 1 article · 1 post — Mastodon 1, Newswires 1Sep 18, 7 PM — quietSep 18, 9 PM — quietSep 18, 11 PM — quietSep 19, 1 AM — quietSep 19, 3 AM — quietSep 19, 5 AM — quietSep 19, 7 AM — 1 piece · 1 article — Google News 1Sep 19, 9 AM — quietSep 19, 11 AM — quietSep 19, 1 PM — quietSep 19, 3 PM — quietSep 19, 5 PM — quietSep 19, 7 PM — quietSep 19, 9 PM — quietSep 19, 11 PM — quietSep 20, 1 AM — quietSep 20, 3 AM — quietSep 20, 5 AM — quietSep 20, 7 AM — quietSep 20, 9 AM — quietSep 20, 11 AM — quietSep 20, 1 PM — quietSep 20, 3 PM — quietSep 20, 5 PM — quietSep 20, 7 PM — quietSep 20, 9 PM — quietSep 20, 11 PM — quietSep 21, 1 AM — quietSep 21, 3 AM — quietSep 21, 5 AM — quietSep 21, 7 AM — quietSep 21, 9 AM — quietSep 21, 11 AM — quietSep 21, 1 PM — quietSep 21, 3 PM — quietSep 21, 5 PM — quietSep 21, 7 PM — quietSep 21, 9 PM — quietSep 21, 11 PM — quietSep 22, 1 AM — quietSep 22, 3 AM — quietSep 22, 5 AM — quietSep 22, 7 AM — quietSep 22, 9 AM — quietSep 22, 11 AM — quietSep 22, 1 PM — quietSep 22, 3 PM — quietSep 22, 5 PM — quietSep 22, 7 PM — quietSep 22, 9 PM — quietSep 22, 11 PM — quietYesterday, 1 AM — quietYesterday, 3 AM — quietYesterday, 5 AM — quietYesterday, 7 AM — quietYesterday, 9 AM — quietYesterday, 11 AM — quietYesterday, 1 PM — quietYesterday, 3 PM — quietYesterday, 5 PM — quietYesterday, 7 PM — quietYesterday, 9 PM — quietYesterday, 11 PM — quietToday, 1 AM — quiet 12
1FDA announces public workshop on…2FDA public workshop on testosterone…
Sep 18Sep 19Sep 20Sep 21Sep 22yesterdaynow · 3:51 AM ET

What was reported 1 claim about this development

  1. 3 outlets U.S. regulators to examine testosterone therapy as use by menopausal women rises

    first by The Hindu, 5d ago · also ABC News, Contemporary OB/GYN

    2 more headlines

All 2 developments of FDA examines testosterone therapy for menopausal women amid… →

NewswiresMastodonGoogle News